Market Design

I post market design related news and items about repugnant markets. See my Stanford profile. I have a forthcoming book : Moral Economics The subtitle is "From Prostitution to Organ Sales, What Controversial Transactions Reveal About How Markets Work."

Showing posts with label hepatitis. Show all posts
Showing posts with label hepatitis. Show all posts
Friday, September 22, 2023

Support for hepatitis C human challenge studies, in The Lancet Gastroenterology & Hepatology

›
 Here's a call for action, in The Lancet Gastroenterology & Hepatology: Joint statement in support of hepatitis C human challenge st...
Saturday, August 26, 2023

Challenge trials for a Hepatitis C vaccine

›
  The Journal Clinical Infectious Diseases has a special supplement on challenge trials (human infection trials) of a Hep C vaccine (now tha...
Monday, May 15, 2023

Eliminating Hepatitis C, now that there's a cure (even though it's expensive)

›
 There's growing discussion about eliminating Hep C in the U.S., doing appropriate deals with the two drug companies whose patents still...
Monday, March 21, 2016

Transplanting kidneys that are infected with hepatitis C (to uninfected patients) or HIV (to already infected patients) to ease the organ shortage

›
Two stories, one on Hep C kidneys to uninfected patients, another on HIV kidneys to patients already infected with HIV. Here's the fi...
Wednesday, August 13, 2014

Good news about a dangerous disease (hepatitis), at a high price

›
The good news is that there's a cure. The bad news is that it isn't cheap. Here's the NY Times headline on what is proving to b...
›
Home
View web version

About Me

Al Roth
View my complete profile
Powered by Blogger.